Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | CASP3 | P42574 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | PRKDC | P78527 | 2/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21929974 | 0.96 | CASP3 (0.47) | MAPTCASP3CYP1A2MEN1KMT2A | |
| SCHEMBL21930007 | 0.86 | MAPK1 (0.47) | MAPTCASP3MEN1KMT2AUSP2 | |
| SCHEMBL22000852 | 0.80 | CASP3 (0.36) | MAPTCASP3MEN1KMT2AUSP2 | |
| SCHEMBL13963497 | 0.79 | CASP3 (0.42) | MAPTCASP3MEN1KMT2AUSP2 | |
| SCHEMBL22000372 | 0.77 | MAPT (0.33) | MAPTCASP3MEN1KMT2AUSP2 | |
| SCHEMBL21929972 | 0.75 | ESR1 (0.39) | MAPTCASP3CYP1A2MEN1KMT2A | |
| SCHEMBL21929971 | 0.74 | CYP1A2 (0.81) | MAPTCYP1A2MEN1KMT2AATM | |
| SCHEMBL21930041 | 0.74 | CYP1A2 (0.81) | MAPTCYP1A2MEN1KMT2AATM | |
| SCHEMBL29352205 | 0.74 | CYP1A2 (0.81) | MAPTCYP1A2MEN1KMT2AATM | |
| SCHEMBL7937231 | 0.74 | CYP1A2 (0.81) | MAPTCYP1A2MEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148541-A1 | AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2020-05-14 | — | — | US | disclosed |
| US-20200148541-A1 | AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148541-A1 | AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS | TYMS, NCL, PFAS | MAPT 1106/4885CASP3 1616/4885CYP1A2 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.